- Surgical Innovations Group, which supplies technology for minimally invasive surgery, said it expected to post 25% growth in annual revenue after a surge in second-half sales.

"Significantly stronger' second-half trading had pushed annual revenue up to around £11.0m, the company said.

Underlying revenue, which strips out the effect of the Elemental Healthcare acquisition, rose around 8%.

'Gross margin was within target range and the resulting increase in profit before tax is anticipated to be in line with board expectations and market consensus,' Surgical Innovations said.

At 8:00am: [LON:SUN] Surgical Innovations Group PLC share price was +0.1p at 3.1p

Story provided by